SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Lock-Up Expiration Hell Portfolio
An SI Board Since May 2001
Posts SubjectMarks Bans
1005 42 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
905Good idea if you could do it. Meanwhile, GENR languishes.tom pope-2/2/2004
904>>One of biotech's poorly conceived projects, this should be an academtuck-2/2/2004
903I seem to recall a biofreak or two finding some kind of fault with the trial restuck-2/2/2004
902POZN up big time on substantially clear data for MT100. The data bolster the NDtuck-1/28/2004
901Cytokinetics, Inc. Files for Initial Public Offering SOUTH SAN FRANCISCO, Califnigel bates-1/28/2004
900POZN hasn't even announced any actual data, but the stock is up smartly on atuck-1/27/2004
899I'm a bit cautious on this one... Macugen involves direct injection to the zeta1961-1/26/2004
898looks like they're bringing it at about $720M, and there are warrants out foscaram(o)uche-1/26/2004
897IPO VIEW-Investors eying blindness drug company Sunday January 25, 12:53 pm ET keokalani'nui-1/26/2004
896One of biotech's poorly conceived projects, this should be an academic pursuscaram(o)uche-1/24/2004
895GNVC, yahoo poster poorgradstudent posts #8041 & 8111 are worth reading for Extra Pale-1/24/2004
894Tuck, The gnvc results appear to be on patients with locally advanced cancer vsExtra Pale-1/24/2004
893Elephants stampeded into GenVec late in the trading session when the following wtuck-1/23/2004
892It's clear from the article you posted that they do not know or understand tBiotech Jim-1/15/2004
891Folks from Arena (ARNA) -- now there's a company in need of a deal -- talk atuck-1/13/2004
89062 pts/arm, 12 weeks and they call this PIII? Here goes another CVTX!Miljenko Zuanic-1/8/2004
889>>GAITHERSBURG, Md., Jan. 8 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaqtuck-1/8/2004
888>>MADISON, Wis. and TOKYO, Jan. 8 /PRNewswire-FirstCall/ -- Third Wave Tectuck-1/8/2004
887Myogen Initiates Phase III Trials of Ambrisentan Thursday January 8, 8:06 am ET nigel bates-1/8/2004
886Advancis Pharmaceutical Corporation Receives First Milestone Payment of $3.0 Milnigel bates-1/8/2004
885>>GAITHERSBURG, Md., Jan. 6 /PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaqtuck-1/6/2004
884>>BOULDER, Colo., Dec 29 /PRNewswire-FirstCall/ -- Pharmion Corporation (Ntuck-1/4/2004
883Genitope.... it's even more complex than just the "personalized"scaram(o)uche-12/22/2003
882I've been meaning to do the same and promise I will someday.keokalani'nui-12/18/2003
881So are any biofreaks looking at the latest round of IPOs? I've heard some gtuck-12/18/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News